Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.

Eur Heart J Open · 2023 · PMC10026620 · PMID 36950450

Europe PMC DOI

hedged sentence

0.2500

closest p · 5.0× alpha

0.2500

boldest claim

The sentences

showed a trendP = 0.25not close (p > 0.1)

HLA class II reactions showed a trend toward reduction ( P = 0.25, Figure 4F ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.